Two-Level nerve block may offer better pain control after breast cancer surgery

NCT ID NCT05361837

Recruiting now Symptom relief Sponsor: National Cancer Institute, Egypt Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study compares two types of nerve blocks for pain relief in women undergoing breast cancer surgery. One group receives a single-level block, while another receives a two-level block, with some patients also getting the medication dexmedetomidine. The goal is to see which approach reduces pain and the need for additional painkillers like morphine. The trial involves 172 participants and will also monitor side effects such as nausea and heart rate changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dexmedetomidine
What this could lead to: If successful, this could lead to a more effective way to manage pain after breast cancer surgery, reducing the need for strong painkillers like morphine.
What could go wrong: This is a single-center study with a moderate number of participants. The results may not apply to all patients, and there is a risk of side effects like nausea, vomiting, or injection-site hematoma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia breast cancer pain agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANALGESIA

Contacts and locations

Locations

Walaa Y Elsabeeny
RECRUITING

Cairo, Cairo Governorate, 11796, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.